BLOG

Cerevance raising $60m for brain disease drug discovery

In the world of Longevity start-ups, it’s amazing how often we speak to founders who have a genuine interest in making a difference – often due to very personal experiences. Brad Margus, CEO of brain disease biopharma firm Cerevance, is a perfect example.

Back to the Blog .st0{stroke:#000;stroke-width:3}.st0,.st1{fill:none}